Basic Information
| LncRNA/CircRNA Name | circ_101237 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | liver cancer tissue and serum |
| Expression Pattern | up-regulated |
| Function Description | In addition, the expression of circRNA_101237 was associated with tumor size, lymph node metastasis, distant metastasis and TNM stage. Univariate and multivariate analysis indicated that serum circRNA_101237 levels were an independent predictor of survival prognosis in patients with HCC. |
| Pubmed ID | 32226487 |
| Year | 2020 |
| Title | Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma |
External Links
| Links for circ_101237 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |